WALTHAM, Mass.--(BUSINESS WIRE)--The population of hospitalized patients with diabetes is on the rise, as is the cost and intensity of their care. Glytec is partnering with the American Hospital Association to deliver a webinar that brings greater attention and awareness to reducing risks and improving safety for patients with diabetes.
The webinar will focus specifically on hypoglycemia, a state of abnormally low blood sugar that can lead to significant complications, including death, and carries substantive financial implications for patients and providers alike. The Centers for Medicare & Medicaid Services (CMS) identifies hypoglycemia as the third most common adverse drug event among hospitalized patients, which is why a hypoglycemia quality measure is currently under development. Are you prepared? Attend the webinar to learn more.
You may register for the webinar here.
Details include:
What
Improving the Quality and
Cost of Diabetes Care
How Florida Hospital System Discovered and
Reduced Hypoglycemia Risks
When
December 13, 2018
1-2
pm Eastern
12-1 pm Central
10-11 am Pacific
Speakers
Dr. Richard E. Pratley
of Florida Hospital System
Dr. Steven V. Edelman of UC San Diego
Health
Description
Hypoglycemia in the
hospital is costly, extremely serious and largely preventable -- and
insulin is the #1 precipitating variable. Given one of every three
hospitalized patients requires insulin therapy during their stay, mainly
those with diabetes, the population susceptible to hypoglycemia is
considerable. This webinar will examine how Florida Hospital System
discovered that patients who experienced hypoglycemia had substantially
higher mortality rates, lengths of stay and readmission rates than
patients with normal glycemia, which added more than $45 million a year
to the cost of care. This webinar will also showcase the series of
strategic initiatives and technology investments that led Florida
Hospital System to achieve marked improvements in outcomes.
Learnings
• The clinical and
financial implications of hypoglycemia
• Uncovering hypoglycemia
risks through data analysis
• What comprises the proposed CMS
hypoglycemia quality measure and how you should prepare
• Steps you
can take to elevate insulin safety, hypoglycemia prevention and glycemic
management as strategic priorities for your hospital
About Glytec
Glytec is the pioneer of personalized digital
therapeutics, enabling best practices for insulin optimization across
the continuum of care. The company’s patented and FDA-cleared
software-as-a-medical-device solutions
improve the safety and health of people with diabetes in the hospital
and at home. Glytec combines evidence-based decision support
technologies with expert clinical services to make insulin a more
effective medication option for the millions unable to achieve their
treatment goals, leading to reductions in A1C, hypoglycemia and other
complications as well as avoidable ED visits, hospitalizations,
readmissions and drug waste. The company has offices in Waltham,
Massachusetts and Greenville, South Carolina. For more information visit www.glytecsystems.com.